Zanthoxylum zanthoxyloides Alkaloidal Extract Improves CCl4-Induced Hepatocellular Carcinoma-Like Phenotypes in Rats

Desmond Omane Acheampong1, Isaac Kyei Baffour1, Victor Yao Atsu Barku2

  • 1Department of Biomedical Sciences, School of Allied Health Sciences, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana.

Abstract

Insights

The alkaloidal extract of Zanthoxylum zanthoxyloides (ZZAE) showed promise in reducing hepatocellular carcinoma (HCC) development in rats. ZZAE demonstrated hepatoprotective effects, suggesting its potential as a natural therapeutic agent against HCC.

Area of Science:

  • Phytochemistry
  • Hepatology
  • Oncology

Background:

  • Hepatocellular carcinoma (HCC) remains a global health challenge despite advancements in treatment.
  • Zanthoxylum zanthoxyloides is a potential source of anticancer compounds for adjunctive therapy.

Purpose of the Study:

  • To evaluate the effects of Zanthoxylum zanthoxyloides alkaloidal extract (ZZAE) on HCC-like phenotypes induced by carbon tetrachloride (CCl4) in rats.
  • To explore the potential of ZZAE as a natural therapeutic agent for HCC.

Main Methods:

  • Preparation and phytochemical characterization of ZZAE.
  • Induction of HCC-like phenotypes in Sprague-Dawley rats using CCl4/olive oil.
  • Treatment of rats with ZZAE, carvedilol, or saline over 12 weeks.
  • Assessment of tumor incidence, liver function markers, and hepatohistology.

Main Results:

  • ZZAE (100 and 200 mg/kg) and carvedilol reduced tumor incidence in rats.
  • ZZAE significantly improved serum GGT levels and hepatohistological distortions.
  • ZZAE demonstrated hepatoprotective effects and arrested mitosis in the Allium cepa assay.

Conclusions:

  • ZZAE ameliorated CCl4/olive oil-induced HCC-like phenotypes in rats.
  • ZZAE exhibited general hepatoprotective effects, improving liver and kidney function markers.
  • Further research into ZZAE as a source of anti-HCC compounds is warranted.

Related Concept Videos